Search
Moderna Inc
MRNAAdd to Watchlist
63.960USD
+2.160+3.50%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
25.38BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Moderna Inc is 5.92, ranking 139 out of 157 in the Pharmaceuticals industry. The average price target is 28.00, with a high of 135.00 and a low of 17.00.
Analyst Rating
Based on
25
analysts
Hold
Current Rating
48.161
Target Price
-22.07%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Moderna Inc
MRNA
25
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Moderna Inc's expected revenue for the next quarter?
Moderna Inc's expected revenue is 101.78M.
What is Moderna Inc's price target?
Analysts forecast that Moderna Inc's price target is USD 28.00, with the highest forecast at USD 135.00 and the lowest forecast at USD 17.00.
How have Moderna IncMRNA's recent earnings per share performed?
The market expectation was USD -3.40, while Moderna IncMRNA's earnings per share (EPS) for the previous quarter was USD -2.11. EPS for the next quarter is expected at USD -2.08.
What is the analyst rating for Moderna Inc?
Based on the ratings of Moderna Inc's stock from 25 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
